Lipophilicity predicts the ability of nonsulphonylurea drugs to block pancreatic beta‐cell KATP channels and stimulate insulin secretion; statins as a test case

KATP ion channels play a key role in glucose‐stimulated insulin secretion. However, many drugs block KATP as “off targets” leading to hyperinsulinaemia and hypoglycaemia. As such drugs are often lipophilic, the aim was to examine the relationship between drug lipophilicity (P) and IC50 for KATP block and explore if the IC50's of statins could be predicted from their lipophilicity and whether this would allow one to forecast their acute action on insulin secretion.

[1]  N. Gao,et al.  Structure of a Pancreatic ATP-Sensitive Potassium Channel , 2017, Cell.

[2]  F. Ashcroft,et al.  KATP channels and islet hormone secretion: new insights and controversies , 2013, Nature Reviews Endocrinology.

[3]  Tara Gomes,et al.  Risk of incident diabetes among patients treated with statins: population based study , 2013, BMJ.

[4]  Daling Zhu,et al.  Rosiglitazone selectively inhibits KATP channels by acting on the KIR6 subunit , 2012, British journal of pharmacology.

[5]  D. Conte Camerino,et al.  Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs , 2012, Journal of Pharmacology and Experimental Therapeutics.

[6]  J. Lindh,et al.  What is a relevant statin concentration in cell experiments claiming pleiotropic effects? , 2011, British journal of clinical pharmacology.

[7]  Daniela Ponce-Balbuena,et al.  Thiopental inhibits function of different inward rectifying potassium channel isoforms by a similar mechanism. , 2010, European journal of pharmacology.

[8]  T. Flagg,et al.  Muscle KATP channels: recent insights to energy sensing and myoprotection. , 2010, Physiological reviews.

[9]  Paul A. Smith,et al.  Somatostatin Inhibits Oxidative Respiration in Pancreatic β-Cells , 2006 .

[10]  F. Ashcroft,et al.  Inhibition of ATP‐sensitive potassium channels by haloperidol , 2004, British journal of pharmacology.

[11]  S. Seino,et al.  Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels. , 2004, European journal of pharmacology.

[12]  G. Trube,et al.  Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[13]  I. Rustenbeck,et al.  Specificity of Nonadrenergic Imidazoline Binding Sites in Insulin‐Secreting Cells and Relation to the Block of ATP‐Sensitive K1 Channels , 2003, Annals of the New York Academy of Sciences.

[14]  O. Andersen,et al.  Genistein can modulate channel function by a phosphorylation-independent mechanism: importance of hydrophobic mismatch and bilayer mechanics. , 2003, Biochemistry.

[15]  F. Ashcroft,et al.  Sulfonylurea stimulation of insulin secretion. , 2002, Diabetes.

[16]  F. Ashcroft,et al.  Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells , 2001, Diabetologia.

[17]  F. Ashcroft,et al.  Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels , 2001, Diabetologia.

[18]  Paul A. Smith,et al.  Somatostatin activates two types of inwardly rectifying K+ channels in MIN‐6 cells , 2001, The Journal of physiology.

[19]  F. Ashcroft,et al.  The antimalarial agent mefloquine inhibits ATP‐sensitive K‐channels , 2000, British journal of pharmacology.

[20]  S. Kühne,et al.  Mechanism of terfenadine block of ATP‐sensitive K+ channels , 2000, British journal of pharmacology.

[21]  N. McKay,et al.  Sensitivity of Kir6.2‐SUR1 currents, in the absence and presence of sodium azide, to the KATP channel inhibitors, ciclazindol and englitazone , 2000, British journal of pharmacology.

[22]  S. Kühne,et al.  Disopyramide block of K(ATP) channels is mediated by the pore-forming subunit. , 2000, Life sciences.

[23]  M. Nakata,et al.  Inhibition by simvastatin, but not pravastatin, of glucose‐induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L‐type Ca2+ channels in rat islet β‐cells , 1999, British journal of pharmacology.

[24]  A. Moorhouse,et al.  Direct effects of tolbutamide on mitochondrial function, intracellular Ca2+ and exocytosis in pancreatic β-cells , 1999, Pflügers Archiv.

[25]  A. Noma,et al.  The antiarrhythmic agent cibenzoline inhibits KATP channels by binding to Kir6.2. , 1998, Biochemical and biophysical research communications.

[26]  F. Ashcroft,et al.  Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. , 1998, Diabetes.

[27]  P. Smith,et al.  Inhibition of the ATP‐sensitive potassium channel from mouse pancreatic β‐cells by surfactants , 1998 .

[28]  H. Nakano,et al.  Inhibitory effects of genistein on ATP‐sensitive K+ channels in rabbit portal vein smooth muscle , 1997, British journal of pharmacology.

[29]  F. Ashcroft,et al.  Phentolamine block of KATP channels is mediated by Kir6.2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Rowe,et al.  Effect of englitazone on KATP and calcium‐activated non‐selective cation channels in CRI‐G1 insulin‐secreting cells , 1997, British journal of pharmacology.

[31]  P. Richardson,et al.  Inhibition of KATP channel activity by troglitazone in CRI-G1 insulin-secreting cells. , 1996, European journal of pharmacology.

[32]  S. Ozanne,et al.  Mg2+‐dependent inhibition of KATP by sulphonylureas in CRI‐G1 insulin‐secreting cells , 1994 .

[33]  F. Ashcroft,et al.  Block of ATP‐sensitive K+ channels in isolated mouse pancreatic β‐cells by 2,3‐butanedione monoxime , 1993, British journal of pharmacology.

[34]  M. Horie,et al.  Disopyramide blocks pancreatic ATP-sensitive K+ channels and enhances insulin release. , 1993, The American journal of physiology.

[35]  M. Kakei,et al.  Inhibition of the ATP‐sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic β‐cells , 1993, British journal of pharmacology.

[36]  F. Ashcroft,et al.  Amantadine and sparteine inhibit ATP‐regulated K‐currents in the insulin‐secreting β‐cell line, HIT‐T15 , 1991, British journal of pharmacology.

[37]  M. Dunne.  Block of ATP‐regulated potassium channels by phentolamine and other α‐adrenoceptor antagonists , 1991 .

[38]  R. Kozlowski,et al.  Barbiturates inhibit ATP‐K+ channels and voltage‐activated currents in CRI‐G1 insulin‐secreting cells , 1991, British journal of pharmacology.

[39]  M. Dunne.  Block of ATP-regulated potassium channels by phentolamine and other alpha-adrenoceptor antagonists. , 1991, British journal of pharmacology.

[40]  R. Kozlowski,et al.  ATP-sensitive K+-channel run-down is Mg2+ dependent , 1990, Proceedings of the Royal Society of London. B. Biological Sciences.

[41]  F. Ashcroft,et al.  Properties of single potassium channels modulated by glucose in rat pancreatic beta‐cells. , 1988, The Journal of physiology.